A Louisiana court room ordered the Japanese drug making company, Takeda, to pay $9 billion in punitive damages after a federal court jury said it hid cancer risks of their Actos diabetes medicine. Studies have shown that there is an increased risk of users devloping bladder cancer after taking Actos for a year or more. Actos entered the market in 1999 by Takeda Pharmaceuticals and Eli Lilly. Before becoming available on the markets, evidence had shown an increase risk of bladder tumors in animals. In the mid 2000′s, epidemiological evidence began to mount that raised the question whether or not the tumor risk was present in humans. The lawsuit alleged that Takeda did not take serious the concerns about the drug’s cancer potential and put many at risk. Even worse, it was alleged that Takeda misled regulators to protect billions in sales. Personal injury and medical malpractice attorneys, Williams DeClark Tuschman, are now offering free consultation for anyone who may have come in contact with the Actos drug. For more information on the Actos litigation, please contact Williams DeClark Tuschman today or call our office at 419-318-0772. We are more than happy to answer any questions you may have. After our free consultation, we will assist you in the next steps of the appropriate action to take.
Jury Awards $9 Billion In Damages in Actos Health Risk Case
| Apr 14, 2014 | Firm News